Results 121 to 130 of about 8,194 (217)

Reply: Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis.

Journal of the American College of Cardiology, 2017
not available reply to Singh A, Geller HI, Falk RH. Val122Ile mt-ATTR Has a Worse Survival Than wt-ATTR Cardiac Amyloidosis. J Am Coll Cardiol.
Maurer, Mathew S, Mundayat, Rajiv, RAPEZZI, CLAUDIO   +2 more
openaire   +3 more sources

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. [PDF]

Nat Commun, 2023
Steinebrei M, Baur J, Pradhan A, Kupfer N, Wiese S, Hegenbart U, Schönland SO, Schmidt M, Fändrich M.   +8 more
europepmc   +1 more source

Wild type ATTR amyloidosis [PDF]

, 2020
openaire   +1 more source

Wild-type transthyretin amyloidosis in female patients [PDF]

, 2015
Arnt V Kristen, Christoph Kimmich, Christoph Röcken, Fabian aus dem Siepen, Hugo A Katus, Katrin Hinderhofer, Ralf Bauer   +6 more
core   +1 more source

ATTR Amyloidosis Concomitant with Parkinsonism and Cardiac Sympathetic Neuropathy. [PDF]

Ann Nucl Cardiol, 2022
Haga F, Oikawa M, Akama J, Kiko T, Yamada S, Yoshihisa A, Nakazato K, Takeishi Y.   +7 more
europepmc   +1 more source

Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan. [PDF]

Intern Med, 2023
Matsushima M, Tarisawa M, Nomura T, Oshima Y, Yoshino M, Shibata Y, Wakita M, Shirai S, Iwata I, Yaguchi H, Yabe I.   +10 more
europepmc   +1 more source

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study [PDF]

, 2015
Candida C Quarta, Carol J Whelan, Dorota M Rowczenio, Janet A Gilbertson, Julian D Gillmore, Marianna Fontana, Philip N Hawkins, Sevda Ozer   +7 more
core   +1 more source

Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals. [PDF]

BMJ Open, 2023
Obici L, Callaghan R, Ablett J, Bibiloni C, Bueser T, Conceição I, Dongiglio F, Farrugia A, Knebel F, Lane T, Larsson LO, Morier A, Nicholas V, Coelho T.   +13 more
europepmc   +1 more source

Glavonoid, a possible supplement for prevention of ATTR amyloidosis. [PDF]

Heliyon, 2021
Matsushita H, Isoguchi A, Okada M, Masuda T, Misumi Y, Tsutsui C, Yamaguchi N, Ichiki Y, Sawashita J, Ueda M, Mizuguchi M, Ando Y.   +11 more
europepmc   +1 more source

Co-Existing ATTR Amyloidosis and Coronary Artery Disease: A Risky Combination. [PDF]

Clin Case Rep
Planchat A, Guijarro D, Musayeb Y, Giannakopoulos G, Giraud R, Poku NK, Py DA, Noble S.   +7 more
europepmc   +1 more source